Day: June 20, 2025

Municipality Finance PlcStock exchange release 20 June 2025 at 10:00 am (EEST) Municipality Finance issues EUR 40 million zero coupon notes under its MTN programme Municipality Finance Plc issues EUR 40 million zero coupon notes on 23 June 2025. The maturity date of the notes is 23 June 2065. MuniFin has a right, but no obligation, to redeem the notes early on 23 June 2035. The notes are issued under MuniFin’s EUR 50 billion programme for the issuance of debt instruments. The offering circular and the final terms of the notes are available in English on the company’s website at https://www.kuntarahoitus.fi/en/for-investors. MuniFin has applied for the notes to be admitted to trading on the Helsinki Stock Exchange maintained by Nasdaq Helsinki. The public trading is expected to commence on 24 June 2025. Goldman Sachs Bank Europe...

Municipality Finance PlcStock exchange release 20 June 2025 at 10:00 am (EEST) Municipality Finance issues EUR 40 million zero coupon notes under its MTN programme Municipality Finance Plc issues EUR 40 million zero coupon notes on 23 June 2025. The maturity date of the notes is 23 June 2065. MuniFin has a right, but no obligation, to redeem the notes early on 23 June 2040. The notes are issued under MuniFin’s EUR 50 billion programme for the issuance of debt instruments. The offering circular and the final terms of the notes are available in English on the company’s website at https://www.kuntarahoitus.fi/en/for-investors. MuniFin has applied for the notes to be admitted to trading on the Helsinki Stock Exchange maintained by Nasdaq Helsinki. The public trading is expected to commence on 24 June 2025. Goldman Sachs Bank Europe...

The supervisory board of Bigbank AS has decided on 18 June 2025 to extend the term of office of Argo Kiltsmann as the member of the management board of Bigbank AS for another 3 years, beginning from the end of the previous term until 30 June 2028. The management board of Bigbank AS will continue with five members: Martin Länts (Chairman of the management board), Ken Kanarik, Argo Kiltsmann Ingo Põder and Mart Veskimägi. Bigbank AS (www.bigbank.eu), with over 30 years of operating history, is a commercial bank owned by Estonian capital. As of 31 May 2025, the bank’s total assets amounted to 3.0 billion euros, with equity of 278 million euros. Operating in nine countries, the bank serves more than 172,000 active customers and employs 600 people. The credit rating agency Moody’s has assigned Bigbank a long-term bank deposit rating...

Update on Fixed Income Investor Meetings   Reference is made to the stock exchange release dated 6 June 2025, regarding fixed income investor meetings. Following engagement with potential investors, BW Energy has decided to not proceed with the issue of a USD 300 million denominated senior unsecured bond. The indicative terms offered under the current market conditions were unfavourable compared to the other funding sources available to the Company. For further information, please contact:  Brice Morlot, CFO BW Energy  +33.7.81.11.41.16  ir@bwenergy.no  About BW Energy:   BW Energy is a growth E&P company with a differentiated strategy targeting proven offshore oil and gas reservoirs through low risk phased developments. The Company has access to existing production facilities to reduce time to first oil and cashflow with lower...

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotech company developing exosome-based therapies for central nervous system injuries, announced today that it has been accepted into the HealthTech Hub (“HTH”) Accelerator Program. Based in Boston, Massachusetts, home to more than 1,000 biotech companies1, HTH is operated by the Advanced Regenerative Manufacturing Institute (“ARMI”) and its BioFabUSA initiative. NurExone’s acceptance into the prestigious HTH Accelerator Program will support the Company’s expansion into the U.S. market following the establishment of Exo-top Inc. (“Exo-TOP”), the Company’s wholly owned U.S. subsidiary dedicated to GMP-compliant exosome manufacturing for clinical development and commercial scale-up. HTH,...

Minutes of the ordinary and extraordinary general meeting of TONNER DRONES Schiltigheim, June 20, 2025 at 8:00 a.m., Tonner Drones (the “Company”) announces the results of its ordinary and extraordinary general meeting. The Ordinary and Extraordinary General Meeting of Shareholders of TONNER DRONES took place on Thursday, June 19, 2025, under the chairmanship of Mr. Diede van den Ouden. Twelve shareholders were present, had given proxy, or voted by mail. Together, they represented 26.95% of the shares and voting rights. The General Meeting adopted all the resolutions presented by the Board of Directors unanimously or by a very large majority. The voting results for each resolution will be posted online, within the time limits provided for by law, on the TONNER DRONES website (https://tonnerdrones.com/finance/), in the General Meetings...

20 June 2025 – Fleet utilisation for May 2025 was 60 per cent.    Safe Zephyrus, Safe Eurus and Safe Notos operated at full capacity in May, achieving 99 to 100 per cent commercial uptime.   As announced, Safe Notos has been awarded a four-year contract with Petrobras in Brazil commencing September 2026 in continuation of its existing contract.   Safe Caledonia commenced operations at the Captain Field in the UK on 02 June 2025.    Safe Boreas is currently being transported to Singapore ahead of her upcoming contract in Australia.  Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The company is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to https://www.prosafe.com   For further information, please contact:   Terje Askvig, CEO  Phone: +47 952 03 886  Reese...

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP BP is a chronic, debilitating and relapsing rare skin disease affecting approximately 27,000 adults in the U.S. whose disease is uncontrolled by systemic corticosteroids Dupixent is now approved in the U.S. to treat eight distinct diseases with underlying type 2 inflammation, including diseases of the skin, gut, and respiratory system that affect a broad range of patients, from infants to elderly people TARRYTOWN, N.Y. and PARIS, June 20, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for the treatment of adult patients with...

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoidApproval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP BP is a chronic, debilitating, and relapsing rare skin disease affecting approximately 27,000 adults in the US whose disease is uncontrolled by systemic corticosteroids Dupixent is now approved in the US to treat eight distinct diseases with underlying type 2 inflammation, including diseases of the skin, gut, and respiratory system that affect a broad range of patients, from infants to elderly peopleParis and Tarrytown, NY, June 20, 2025. The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of adult patients with bullous...

The shareholders of AS LHV Varahaldus, AS LHV Kindlustus, and AS LHV Finance, belonging to the consolidation group of AS LHV Group, intend to elect, starting from 22 July 2025, Mihkel Torim as a new Member of the Supervisory Board, who will also assume the position of the Chairman of the Management Board of AS LHV Group on the same date. The Member of the Supervisory Board is elected for up to five years. The decision on the compliance of the new Member of the Supervisory Board with the suitability requirements will also be made by the Financial Supervision Authority. Mihkel Torim joined LHV at the beginning of 2023, when he assumed responsibility for managing and developing the investment banking operations of LHV Pank. Prior to that, he held senior positions at Swedbank, including the Head of Baltic Investment Banking, and also led the...